Page last updated: 2024-11-05

tripelennamine and Arteriosclerosis Obliterans

tripelennamine has been researched along with Arteriosclerosis Obliterans in 1 studies

Tripelennamine: A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.

Arteriosclerosis Obliterans: Common occlusive arterial disease which is caused by ATHEROSCLEROSIS. It is characterized by lesions in the innermost layer (ARTERIAL INTIMA) of arteries including the AORTA and its branches to the extremities. Risk factors include smoking, HYPERLIPIDEMIA, and HYPERTENSION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BAIRD, RJ1
MIYAGISHIMA, RT1
LABROSSE, CJ1

Other Studies

1 other study available for tripelennamine and Arteriosclerosis Obliterans

ArticleYear
VASODILATING ACTION OF INTRA-ARTERIAL OXYGEN EMBOLI.
    Archives of surgery (Chicago, Ill. : 1960), 1964, Volume: 88

    Topics: Acetylcholine; Arteriosclerosis Obliterans; Atropine; Blood Flow Velocity; Blood Pressure; Dogs; Emb

1964
chemdatabank.com